Assessing depressive symptoms in multiple sclerosis: Is it necessary to omit items from the original Beck Depression Inventory?

被引:77
作者
Aikens, JE
Reinecke, MA
Pliskin, NH
Fischer, JS
Wiebe, JS
McCracken, LM
Taylor, JL
机构
[1] Univ Chicago, Med Ctr, Dept Psychiat, Chicago, IL 60637 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44106 USA
关键词
depression; assessment; multiple sclerosis; Beck Depression Inventory;
D O I
10.1023/A:1018731415172
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Overlap between depression scale item content and medical symptoms may exaggerate depression estimates for patients with multiple sclerosis (MS). We reconsider Mohr and co-workers' (1997) recommendation to omit Beck Depression Inventory (BDI) items assessing work ability (item 15), fatigue (17), and health concerns (20) for MS patients. Subjects were medical patients with either MS (n = 105) or a medical disorder for which the BDI is empirically supported [diabetes mellitus (DM), n 71; chronic pain (CP), n = 80], psychiatric patients with depressive disorder (MDD; n = 37), and healthy controls (HC; n = 80). Relative scores for the eight "somatic" BDI items were analyzed By multivariate analysis of variance with demographic variables and BDI total as covariates. The only significant difference was MS > HC (item 15). On raw scores, MS patients exceeded HCs on items 15 and 21 (sexual disinterest), but this was attributable to the low HC item endorsement. There were no other differences on somatic items or item-total correlations. Scale consistency was good across groups, regardless of item omission. Somatic items were unassociated with major MS parameters. We thus encourage continued application of the frill BDI for assessing depressive, symptoms in patients with MS.
引用
收藏
页码:127 / 142
页数:16
相关论文
共 47 条
  • [11] First MB, 1995, STRUCTURED CLIN INTE
  • [12] IMPROVEMENT OF ADHESION OF CO-CR LAYERS BY PLASMA SURFACE MODIFICATIONS OF THE PET SUBSTRATE
    FISCHER, G
    HAGEMEYER, A
    DEMBOWSKI, J
    HIBST, H
    [J]. JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY, 1994, 8 (02) : 151 - 161
  • [13] Assessing depression among persons with chronic pain using the center for epidemiological studies depression scale and the beck depression inventory: A comparative analysis
    Geisser, ME
    Roth, RS
    Robinson, ME
    [J]. CLINICAL JOURNAL OF PAIN, 1997, 13 (02) : 163 - 170
  • [14] SUBCLINICAL AND CLINICAL DEPRESSION - ARE ANALOG STUDIES JUSTIFIABLE
    HILL, AB
    KEMPWHEELER, SM
    JONES, SA
    [J]. PERSONALITY AND INDIVIDUAL DIFFERENCES, 1987, 8 (01) : 113 - 120
  • [15] COGNITIVE THERAPY FOR DEPRESSION - CONCEPTUAL ISSUES AND CLINICAL EFFICACY
    HOLLON, SD
    SHELTON, RC
    DAVIS, DD
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1993, 61 (02) : 270 - 275
  • [16] HUBER SJ, 1993, NEUROPSY NEUROPSY BE, V6, P177
  • [17] ISOMETSA ET, 1994, J CLIN PSYCHIAT, V55, P523
  • [18] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis
    Jacobs, LD
    Cookfair, DL
    Rudick, RA
    Herndon, RM
    Richert, JR
    Salazar, AM
    Fischer, JS
    Goodkin, DE
    Granger, CV
    Simon, JH
    Alam, JJ
    Bartoszak, DM
    Bourdette, DN
    Braiman, J
    Brownscheidle, CM
    Coats, ME
    Cohan, SL
    Dougherty, DS
    Kinkel, RP
    Mass, MK
    Munschauer, FE
    Priore, RL
    Pullicino, PM
    Scherokman, BJ
    WeinstockGuttman, B
    Whitman, RH
    Baird, WC
    Fillmore, M
    Bona, LM
    ColonRuiz, ME
    Nadine, BS
    Donovan, A
    Bennett, S
    Kieffer, YM
    Umhauer, MA
    Miller, CE
    Kilic, AK
    Sargent, EL
    Schachter, M
    Shucard, DW
    Weider, V
    Catalano, BA
    Cervi, JM
    Czekay, C
    Farrell, JL
    Filippini, JS
    Matyas, RC
    Michienzi, KE
    Ito, M
    OMalley, JA
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 285 - 294
  • [19] MOOD DISORDER AND MULTIPLE-SCLEROSIS
    JOFFE, RT
    LIPPERT, GP
    GRAY, TA
    SAWA, G
    HORVATH, Z
    [J]. ARCHIVES OF NEUROLOGY, 1987, 44 (04) : 376 - 378
  • [20] COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    JOHNSON, KP
    BROOKS, BR
    COHEN, JA
    FORD, CC
    GOLDSTEIN, J
    LISAK, RP
    MYERS, LW
    PANITCH, HS
    ROSE, JW
    SCHIFFER, RB
    VOLLMER, T
    WEINER, LP
    WOLINSKY, JS
    BIRD, SJ
    CONSTANTINESCU, C
    KOLSON, DL
    GONZALEZSCARANO, F
    BRENNAN, D
    PFOHL, D
    MANDLER, RN
    ROSENBERG, GA
    JEFFREY, C
    BARGER, GR
    GANDHI, B
    MOORE, PM
    ROGERS, LR
    LISAK, D
    SMITH, L
    ELLISON, GW
    BAUMHEFNER, RW
    CRAIG, SL
    JALBUT, SS
    KATZ, E
    CONWAY, KL
    BURNS, JB
    SHIBA, C
    GIANG, DW
    PETRIE, MD
    GUARNACCIA, JB
    ANDERSON, S
    MCKEON, A
    MCCARTHY, M
    THOMAS, AB
    VRIESENDORP, FJ
    AUSTIN, SG
    LINDSEY, JW
    DIMACHKIE, M
    CERRETA, E
    KACHUCK, N
    MCCARTHY, KA
    [J]. NEUROLOGY, 1995, 45 (07) : 1268 - 1276